Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
24 03 2020
Historique:
received: 05 10 2019
accepted: 12 03 2020
entrez: 25 3 2020
pubmed: 25 3 2020
medline: 10 4 2021
Statut: epublish

Résumé

Germinal centres (GCs) are T follicular helper cell (Tfh)-dependent structures that form in response to vaccination, producing long-lived antibody secreting plasma cells and memory B cells that protect against subsequent infection. With advancing age the GC and Tfh cell response declines, resulting in impaired humoral immunity. We sought to discover what underpins the poor Tfh cell response in ageing and whether it is possible to correct it. Here, we demonstrate that older people and aged mice have impaired Tfh cell differentiation upon vaccination. This deficit is preceded by poor activation of conventional dendritic cells type 2 (cDC2) due to reduced type 1 interferon signalling. Importantly, the Tfh and cDC2 cell response can be boosted in aged mice by treatment with a TLR7 agonist. This demonstrates that age-associated defects in the cDC2 and Tfh cell response are not irreversible and can be enhanced to improve vaccine responses in older individuals.

Identifiants

pubmed: 32204792
doi: 10.7554/eLife.52473
pii: 52473
pmc: PMC7093110
doi:
pii:

Substances chimiques

CD11 Antigens 0
Ifnar1 protein, mouse 0
Influenza Vaccines 0
Itgax protein, mouse 0
Receptor, Interferon alpha-beta 156986-95-7

Banques de données

GEO
['GSE133148', 'GSE74813']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/B/000C0407
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/B/000C0408
Pays : United Kingdom
Organisme : H2020 Marie Skłodowska-Curie Actions
ID : 675395
Organisme : H2020 European Research Council
ID : 637801

Informations de copyright

© 2020, Stebegg et al.

Déclaration de conflit d'intérêts

MS, AB, DH, AS, CK, IV, SI, LB, JW, MZ, JD, JC, AL, EC, ML No competing interests declared

Références

Nat Immunol. 2011 Jul 10;12(8):786-95
pubmed: 21743478
Nat Commun. 2019 Jun 4;10(1):2443
pubmed: 31164642
Vaccine. 2006 Feb 20;24(8):1159-69
pubmed: 16213065
Bioinformatics. 2002;18 Suppl 1:S96-104
pubmed: 12169536
J Exp Med. 2019 Mar 4;216(3):621-637
pubmed: 30723095
J Exp Med. 1996 Mar 1;183(3):959-70
pubmed: 8642299
Age (Dordr). 2011 Sep;33(3):363-76
pubmed: 20953722
Age (Dordr). 2013 Apr;35(2):371-81
pubmed: 22282053
J Exp Med. 2010 Dec 20;207(13):2895-906
pubmed: 21098093
Immunol Cell Biol. 1998 Feb;76(1):34-40
pubmed: 9553774
Immunology. 2017 Oct;152(2):185-194
pubmed: 28628194
J Exp Med. 2004 Dec 20;200(12):1613-22
pubmed: 15611289
Front Immunol. 2017 Jul 26;8:896
pubmed: 28798751
Br J Dermatol. 2007 Dec;157 Suppl 2:8-13
pubmed: 18067624
J Immunol. 2014 Mar 1;192(5):2156-66
pubmed: 24489092
J Exp Med. 2019 Jul 1;216(7):1561-1581
pubmed: 31072818
Sci Transl Med. 2013 Mar 13;5(176):176ra32
pubmed: 23486778
J Exp Med. 2017 Jul 3;214(7):2139-2152
pubmed: 28637884
J Immunol. 2003 Dec 1;171(11):5975-87
pubmed: 14634109
J Immunol. 2016 Nov 15;197(10):3884-3893
pubmed: 27798160
J Immunol. 2001 Mar 1;166(5):3151-7
pubmed: 11207267
Gerontology. 2013;59(5):421-6
pubmed: 23615484
J Immunol. 2002 Jul 1;169(1):375-83
pubmed: 12077267
Bioinformatics. 2004 Feb 12;20(3):307-15
pubmed: 14960456
Front Immunol. 2018 Oct 25;9:2469
pubmed: 30410492
J Immunol. 1998 Aug 15;161(4):1947-53
pubmed: 9712065
Genome Biol. 2014;15(12):550
pubmed: 25516281
Clin Sci (Lond). 2018 Sep 5;132(17):1925-1935
pubmed: 30185614
Immunol Rev. 2003 Aug;194:8-18
pubmed: 12846803
Immunol Cell Biol. 2014 Jan;92(1):72-9
pubmed: 24217812
Annu Rev Immunol. 2016 May 20;34:335-68
pubmed: 26907215
J Exp Med. 2019 Aug 5;216(8):1857-1873
pubmed: 31175140
PLoS One. 2010 Nov 15;5(11):e13984
pubmed: 21085593
Aging Cell. 2012 Oct;11(5):732-40
pubmed: 22607653
J Clin Invest. 2011 Aug;121(8):3109-19
pubmed: 21785218
JAMA. 1994 Dec 7;272(21):1661-5
pubmed: 7966893
Elife. 2013 Jul 16;2:e00299
pubmed: 23878721
Antimicrob Agents Chemother. 1999 Apr;43(4):856-61
pubmed: 10103191
Nat Commun. 2014 Oct 03;5:5074
pubmed: 25278262
J Immunol. 2017 Apr 1;198(7):2819-2833
pubmed: 28250157
Clin Infect Dis. 2014 Nov 1;59(9):1246-55
pubmed: 25048848
Nature. 2011 Jun 15;474(7351):337-42
pubmed: 21677750
J Immunol. 2006 Feb 15;176(4):2074-8
pubmed: 16455962
Front Immunol. 2019 Apr 12;10:778
pubmed: 31031767
J Immunol. 2011 Aug 1;187(3):1091-5
pubmed: 21715693
Nat Commun. 2013;4:1560
pubmed: 23463003
Blood. 2009 Mar 12;113(11):2426-33
pubmed: 19020307
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Immunity. 2015 Dec 15;43(6):1186-98
pubmed: 26682988
Nucleic Acids Res. 2019 May 7;47(8):e47
pubmed: 30783653
Cell Rep. 2020 Jan 7;30(1):137-152.e5
pubmed: 31914381
Lab Anim. 2014 Feb 4;48(3):178-192
pubmed: 24496575
J Immunol. 2010 Aug 1;185(3):1558-67
pubmed: 20601593
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
J Exp Med. 2007 Jul 9;204(7):1653-64
pubmed: 17591855
Front Immunol. 2018 Oct 12;9:2370
pubmed: 30369932
Anat Rec. 1990 Aug;227(4):475-85
pubmed: 2393099
Sci Transl Med. 2017 Mar 22;9(382):
pubmed: 28330867
Nature. 2014 May 29;509(7502):637-40
pubmed: 24805232
J Allergy Clin Immunol. 2015 Nov;136(5):1387-97.e1-7
pubmed: 25962902
J Exp Med. 2014 Jul 28;211(8):1611-21
pubmed: 25049334
Vaccine. 1993;11(6):649-54
pubmed: 8322488
Trends Immunol. 2015 Mar;36(3):124-38
pubmed: 25704559
Clin Cancer Res. 2011 May 1;17(9):2619-27
pubmed: 21372217
J Exp Med. 2014 Jan 13;211(1):45-56
pubmed: 24367004
Nat Immunol. 2018 Jan;19(1):10-19
pubmed: 29242543
Vaccine. 2005 Jan 4;23(7):946-50
pubmed: 15603897
BMC Infect Dis. 2001;1:3
pubmed: 11401728
Front Immunol. 2018 Sep 27;9:2169
pubmed: 30319629
J Immunol. 2007 Jun 1;178(11):6912-22
pubmed: 17513740
J Exp Med. 2009 Mar 16;206(3):561-76
pubmed: 19221396
Immunology. 2017 Jun;151(2):239-247
pubmed: 28207940
EMBO Mol Med. 2014 May 01;6(5):590-603
pubmed: 24737871
J Exp Med. 2011 Nov 21;208(12):2497-510
pubmed: 22042977
Br J Dermatol. 2003 Nov;149 Suppl 66:5-8
pubmed: 14616337
Sci Immunol. 2017 Dec 1;2(18):
pubmed: 29196450
Immunology. 1989 Nov;68(3):312-8
pubmed: 2592007
Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):524-9
pubmed: 25548162
Immunity. 2018 Mar 20;48(3):584-598.e5
pubmed: 29548673
Curr Opin Virol. 2011 Dec;1(6):463-75
pubmed: 22440910
J Immunol. 2015 Jun 1;194(11):5187-99
pubmed: 25917099
Nat Methods. 2015 Apr;12(4):357-60
pubmed: 25751142
Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10338-43
pubmed: 10468609
J Invest Dermatol. 2017 Sep;137(9):1905-1913
pubmed: 28457909
Lancet Infect Dis. 2016 Feb;16(2):209-18
pubmed: 26559482
J Immunol. 2010 Mar 1;184(5):2518-27
pubmed: 20100933
Immunity. 2016 Sep 20;45(3):669-684
pubmed: 27637149
Eur J Immunol. 2006 Sep;36(9):2315-23
pubmed: 16933361
Cell Rep. 2015 Jul 14;12(2):163-71
pubmed: 26146074
Eur J Immunol. 1997 Jun;27(6):1381-6
pubmed: 9209488
J Immunol. 2014 Apr 15;192(8):3607-17
pubmed: 24646739
Nat Biotechnol. 2014 Sep;32(9):896-902
pubmed: 25150836
J Immunol. 2008 Nov 15;181(10):6747-56
pubmed: 18981092
J Immunol. 2017 Jan 1;198(1):375-382
pubmed: 27872213
Antimicrob Agents Chemother. 1988 May;32(5):678-83
pubmed: 2840014
J Immunol. 2008 Dec 1;181(11):7977-84
pubmed: 19017989
Methods Mol Biol. 2010;626:169-85
pubmed: 20099128
Immunity. 2013 Mar 21;38(3):596-605
pubmed: 23499493
Sci Rep. 2013;3:2327
pubmed: 23900141
Immunity. 2009 Sep 18;31(3):491-501
pubmed: 19733096
J Leukoc Biol. 1994 Feb;55(2):234-40
pubmed: 7507969
PLoS One. 2015 Jun 23;10(6):e0129858
pubmed: 26103163
Cell. 2010 Nov 12;143(4):592-605
pubmed: 21074050

Auteurs

Marisa Stebegg (M)

Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom.

Alexandre Bignon (A)

Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom.

Danika Lea Hill (DL)

Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom.

Alyssa Silva-Cayetano (A)

Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom.

Christel Krueger (C)

Epigenetics Programme, Babraham Institute, Cambridge, United Kingdom.

Ine Vanderleyden (I)

Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom.

Silvia Innocentin (S)

Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom.

Louis Boon (L)

Bioceros BV, Utrecht, Netherlands.

Jiong Wang (J)

Division of Nephrology, Department of Medicine and Clinical and Translational Science Institute, University of Rochester Medical Center, Rochester, United States.

Martin S Zand (MS)

Division of Nephrology, Department of Medicine and Clinical and Translational Science Institute, University of Rochester Medical Center, Rochester, United States.

James Dooley (J)

Autoimmune Genetics Laboratory, VIB and University of Leuven, Leuven, Belgium.

Jonathan Clark (J)

Biological Chemistry, Babraham Institute, Cambridge, United Kingdom.

Adrian Liston (A)

Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom.

Edward Carr (E)

Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom.
Department of Medicine, University of Cambridge, Cambridge, United Kingdom.

Michelle A Linterman (MA)

Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH